Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 38 Records) |
Query Trace: SLC28A3[original query] |
---|
SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours. British journal of cancer 2014 Jan 110 (2): 304-12. Khatri A, Williams B W, Fisher J, Brundage R C, Gurvich V J, Lis L G, Skubitz K M, Dudek A Z, Greeno E W, Kratzke R A, Lamba J K, Kirstein M |
Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy. European journal of cancer (Oxford, England : 1990) 2014 Mar 50 (4): 698-705. Lee Soo-Youn, Im Seock-Ah, Park Yeon Hee, Woo Sook Young, Kim Seonwoo, Choi Moon Ki, Chang Wonjin, Ahn Jin Seok, Im Young-Hyu |
Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes. Pharmacogenomics 2014 Mar 15 (4): 433-47. Matimba Alice, Li Fang, Livshits Alina, Cartwright Cher S, Scully Stephen, Fridley Brooke L, Jenkins Gregory, Batzler Anthony, Wang Liewei, Weinshilboum Richard, Lennard Lyn |
Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients. Pharmacogenomics 2015 Jul 16 (10): 1119-34. Hareedy Mohammad Salem, El Desoky Ehab S, Woillard Jean-Baptiste, Thabet Romany Helmy, Ali Amany Mohamad, Marquet Pierre, Picard Nicol |
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast cancer research and treatment 2015 Jul 152 (1): 67-76. Vulsteke Christof, Pfeil Alena M, Maggen Charlotte, Schwenkglenks Matthias, Pettengell Ruth, Szucs Thomas D, Lambrechts Diether, Dieudonné Anne-Sophie, Hatse Sigrid, Neven Patrick, Paridaens Robert, Wildiers Ha |
Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma. Pharmacogenomics 2015 16 (4): 361-72. Reichwagen Annegret, Ziepert Marita, Kreuz Markus, Gödtel-Armbrust Ute, Rixecker Tanja, Poeschel Viola, Reza Toliat Mohammad, Nürnberg Peter, Tzvetkov Mladen, Deng Shiwei, Trümper Lorenz, Hasenfuss Gerd, Pfreundschuh Michael, Wojnowski Lesz |
Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia. Pediatric blood & cancer 2015 Apr 62 (4): 622-8. Gabor Krisztina Mita, Schermann Geza, Lautner-Csorba Orsolya, Rarosi Ferenc, Erdelyi Daniel J, Endreffy Emoke, Berek Krisztina, Bartyik Katalin, Bereczki Csaba, Szalai Csaba, Semsei Agnes |
Exploring Variation in Known Pharmacogenetic Variants and its Association with Drug Response in Different Mexican Populations. Pharmaceutical research 2016 Jul . Gonzalez-Covarrubias Vanessa, Martínez-Magaña José Jaime, Coronado-Sosa Regina, Villegas-Torres Beatriz, Genis-Mendoza Alma D, Canales-Herrerias Pablo, Nicolini Humberto, Soberón Xavi |
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy. AIDS (London, England) 2016 May . Kheloufi Farid, Bellissant Eric, Cotte Laurent, Poizot-Martin Isabelle, Quaranta Sylvie, Garraffo Rodolphe, Barrail-Tran Aurélie, Renault Alain, Fournier Isabelle, Lacarelle Bruno, Bourlière Marc, Molina Jean-Michel, Solas Caroline, |
Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines. Pharmacogenomics 2016 Jan . Hertz Daniel L, Caram Megan V, Kidwell Kelley M, Thibert Jacklyn N, Gersch Christina, Seewald Nicholas J, Smerage Jeffrey, Rubenfire Melvyn, Henry N Lynn, Cooney Kathleen A, Leja Monika, Griggs Jennifer J, Rae James |
Rare coding variants associated with blood pressure variation in 15?914 individuals of African ancestry.
Journal of hypertension 2017 Feb . Nandakumar Priyanka, Lee Dongwon, Richard Melissa A, Tekola-Ayele Fasil, Tayo Bamidele O, Ware Erin, Sung Yun J, Salako Babatunde, Ogunniyi Adesola, Gu C Charles, Grove Megan L, Fornage Myriam, Kardia Sharon, Rotima Charles, Cooper Richard S, Morrison Alanna C, Ehret Georg, Chakravarti Aravin |
A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer. Oncotarget 2017 Nov 8 (57): 96893-96902. Jo Jung Ki, Oh Jong Jin, Kim Yong Tae, Moon Hong Sang, Choi Hong Yong, Park Seunghyun, Ho Jin-Nyoung, Yoon Sungroh, Park Hae Young, Byun Seok-S |
Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia. Current drug metabolism 2017 11 19 (1): 55-74. Megias-Vericat Juan Eduardo, Martinez-Cuadron David, Herrero Maria Jose, Alino Salvador F, Poveda Jose Luis, Sanz Miguel Angel, Montesinos P |
Correction: A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer. Oncotarget 2018 8 9 (61): 31938. Jo Jung Ki, Oh Jong Jin, Kim Yong Tae, Moon Hong Sang, Choi Hong Yong, Park Seunghyun, Ho Jin-Nyoung, Yoon Sungroh, Park Hae Young, Byun Seok-S |
Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma. BMC cancer 2018 Jul 18 (1): 704. Sági Judit C, Egyed Bálint, Kelemen Andrea, Kutszegi Nóra, Hegyi Márta, Gézsi András, Herlitschke Martina Ayaka, Rzepiel Andrea, Fodor Lili E, Ottóffy Gábor, Kovács Gábor T, Erdélyi Dániel J, Szalai Csaba, Semsei Ágnes |
Chemotherapy-Related Cardiac Dysfunction: A Systematic Review of Genetic Variants Modulating Individual Risk. Circulation. Genomic and precision medicine 2018 01 11 (1): e001753. Linschoten Marijke, Teske Arco J, Cramer Maarten J, van der Wall Elsken, Asselbergs Folkert |
Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation. Clinical pharmacokinetics 2018 11 58 (5): 593-613. Tron Camille, Lemaitre Florian, Verstuyft Céline, Petitcollin Antoine, Verdier Marie-Clémence, Bellissant Er |
Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3. Genetic testing and molecular biomarkers 2018 10 22 (11): 652-655. Stansberry Wesley M, Swart Marelize, Medeiros Elizabeth B, Skaar Todd C, Pratt Victoria |
Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancer. Cancer science 2019 Sep . Makino Yoshinori, Makihara-Ando Reiko, Ogawa Takanori, Sato Hitoshi, Goto Yasushi, Kanda Shintaro, Horinouchi Hidehito, Fujiwara Yutaka, Ohe Yuichiro, Yamamoto Nobo |
Pathway genes and metabolites in thiopurine therapy in Korean children with acute lymphoblastic leukaemia. British journal of clinical pharmacology 2019 Mar . Choi Rihwa, Sohn Insuk, Kim Min-Ji, Woo Hye In, Lee Ji Won, Ma Youngeun, Yi Eun Sang, Koo Hong Hoe, Lee Soo-Yo |
Association of SLC28A3 Gene Expression and CYP2B6*6 Allele with the Response to Fludarabine Plus Cyclophosphamide in Chronic Lymphocytic Leukemia Patients. Pathology oncology research : POR 2019 Feb . Vukovic Vojin, Karan-Djurasevic Teodora, Antic Darko, Tosic Natasa, Kostic Tatjana, Marjanovic Irena, Dencic-Fekete Marija, Djurasinovic Vladislava, Pavlovic Sonja, Mihaljevic Bilja |
Genetic and clinical determinants of mizoribine pharmacokinetics in renal transplant recipients. European journal of clinical pharmacology 2020 8 77 (1): 45-53. Dai Rui, Li Jingjie, Wu Jingjing, Fu Qian, Yan Jiajia, Zhong Guoping, Wang Changxi, Chen Xiao, Chen P |
Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients.
Annals of the rheumatic diseases 2020 05 79 (5): 657-665. Nakayama Akiyoshi, Nakatochi Masahiro, Kawamura Yusuke, Yamamoto Ken, Nakaoka Hirofumi, Shimizu Seiko, Higashino Toshihide, Koyama Teruhide, Hishida Asahi, Kuriki Kiyonori, Watanabe Miki, Shimizu Toru, Ooyama Keiko, Ooyama Hiroshi, Nagase Mitsuo, Hidaka Yuji, Matsui Daisuke, Tamura Takashi, Nishiyama Takeshi, Shimanoe Chisato, Katsuura-Kamano Sakurako, Takashima Naoyuki, Shirai Yuya, Kawaguchi Makoto, Takao Mikiya, Sugiyama Ryo, Takada Yuzo, Nakamura Takahiro, Nakashima Hiroshi, Tsunoda Masashi, Danjoh Inaho, Hozawa Atsushi, Hosomichi Kazuyoshi, Toyoda Yu, Kubota Yu, Takada Tappei, Suzuki Hiroshi, Stiburkova Blanka, Major Tanya J, Merriman Tony R, Kuriyama Nagato, Mikami Haruo, Takezaki Toshiro, Matsuo Keitaro, Suzuki Sadao, Hosoya Tatsuo, Kamatani Yoichiro, Kubo Michiaki, Ichida Kimiyoshi, Wakai Kenji, Inoue Ituro, Okada Yukinori, Shinomiya Nariyoshi, Matsuo Hirotaka, |
Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Feb . Peddi Parvin F, Fasching Peter A, Liu Duan, Quinaux Emmanuel, Robert Nicholas J, Valero Vicente, Crown John, Falkson Carla, Brufsky Adam, Cunningham Julie M, Weinshilboum Richard M, Pienkowski Tadeusz, Eiermann Wolfgang, Martín Miguel, Bee Valerie, Wang Xiaoyan, Wang Liewei, Yang Eric, Slamon Dennis J, Hurvitz Sara |
Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study. JMIR research protocols 2022 2 11 (2): e27898. Zolk Oliver, von dem Knesebeck Annika, Graf Norbert, Simon Thorsten, Hero Barbara, Abdul-Khaliq Hashim, Abd El Rahman Mohamed, Spix Claudia, Mayer Benjamin, Elsner Susanne, Gebauer Judith, Langer Thorst |
Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients. Pharmacogenomics 2022 2 23 (5): 291-301. Vargas-Neri Jessica L, Carleton Bruce, Ross Colin J, Medeiros Mara, Castañeda-Hernández Gilberto, Clark Patric |
Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review. BMC cancer 2022 12 22 (1): 1326. Hurkmans Evelien G E, Brand Annouk C A M, Verdonschot Job A J, Te Loo D Maroeska W M, Coenen Marieke J |
Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study. JCO precision oncology 2023 3 7 e2200580. Larkin Trisha, Kashif Reema, Elsayed Abdelrahman H, Greer Beate, Mangrola Karna, Raffiee Roya, Nguyen Nam, Shastri Vivek, Horn Biljana, Lamba Jatinder |
Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity. Therapeutic drug monitoring 2023 2 . Siemens Angela, Rassekh Shahrad Rod, Ross Colin J D, Carleton Bruce |
Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients. British journal of clinical pharmacology 2023 1 . Nyangwara Vincent Aketch, Mazhindu Tinashe, Chikwambi Zedias, Masimirembwa Collen, Campbell Thomas B, Borok Margaret, Ndlovu Ntoko |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: